having 1 -carboxyethoxyimino groups were synthesized and found to have excellent antibacterial activities including anti-pseudomonal activity and low toxicities. Among these cephalosporins, ME1228 having (S)-1-carboxyethoxyimino substituent and being combined with an (7V-ethyl-4-pyridinio)thiomethyl group at C-3 showed marked therapeutic effects against systemic infections in mice and was selected as the best candidate for further evaluation.
Gram-positive and Gram-negative bacteria including Pseudomonas aeruginosa. 1'^In this paper, we wish to report the synthesis of ME1228and related analogues, and their antibacterial activities and toxicities.
Chemistry
Several aminothiazolylacetamidocephalosporins having 1 -carboxyalkoxyimino substituents3) on the acetamido group and (A^-alkyl-4-pyridinio)thiomethyl substituents4) at C-3 were synthesized. The best compound, ME1228(1) was prepared as shown in Scheme 1. Alkylation3) of the hydroxyimino moiety of allyl 2-(2-tritylaminothiazol-4-yl)-2-hydroxyiminoacetate5) (2) with diphenylmethyl (i?)-2-chloropropionate (3) in the presence of finely powdered potassium carbonate in dimethyl sulfoxide at room temperature afforded 4. The allyl protecting group of 4 was removed by palladium catalyzed reaction6) with Pd(Ph3P)4 in the presence of potassium 2-ethylhexanoate in ethyl acetate to give the potassium salt (5a), followed by treatment with dilute acid to give the chiral acid (5b) in 48% yield from 2. 77-Methoxybenzyl (6JR,7i?)-7-amino-3-chloromethylceph-3-em-4-carboxylate7) (6) was reacted with 5b and phosphoryl chloride in the presence of pyridine in dichloromethane at -10°C to afford 7 in 87% yield. Compound7 was reacted with l-ethylpyrid-4-thione8) (8) in dimethyl sulfoxide at room temperature to give 9 in 85% yield. Deprotection of 9 was performed with formic acid containing hydrochloric acid in the presence of anisole to give 1 in 78%yield. Compound1 was crystallized as the stable dihydrochloride in fine needles from aqueous acetone containing 6 equivalents of hydrochloric acid.
Compound 3 was derived from diphenylmethyl (S)-2-hydroxypropionate (10) by reaction with sulfuryl chloride in N,7V-dimethylformamide at -40°C in 78% yield (Scheme 2). Diphenylmethyl (S)-2- Compounds 13 and 16 ( Fig. 1) were obtained from ll by the aforementioned reaction sequence. l-Methyl-4-pyridinio analogues (15~18) were prepared similarly with l-methylpyrid-4-thione instead of 8. 1-Carboxy-l-methylethoxyimino compounds (14 and 17) were prepared by a known method.10'11* The demethyl analogue 18 is a known compound.4*
Antibacterial
Activity and Toxicity
The in vitro antibacterial activity and acute toxicity in mice are shown in Table 1 . Aminothiazolylacetamidocephalosporins having 1-carboxy-l-methylethoxyimino group3'10* including ceftazidime (CAZ) are known to have potent anti-pseudomonal activity.
In this series the 1-carboxy-l-methylethoxyimino compounds (14 and 17) showed also good anti-pseudomonal activity, but possessed relatively high toxicity (LD50 in mice, iv; < 1 g/kg). The demethyl analogue 18 markedly lowered toxicity (LD50 > 3 g/kg), but decreased anti-pseudomonal activity. The 1-caboxyethoxyimino compounds (1, 13, 15 and 16) showed promising activity against /Mactamase producers including Escherichia coli and P. aeruginosa, and displayed low toxicity (LD5O>3g/kg). The stereochemistry of the chiral 1-carboxyethoxyimino moiety influenced the activity, and the S isomers (1 and 15) appeared superior to the R isomers (13 and 16). The iV-alkyl group of the pyridinium moiety also had some influence on the activity, and TV-ethyl compounds were selected for further studies. Compound 1 showed better activity against both Gram-positive and Gram-negative bacteria, compared to CAZ. The anti-pseudomonal activity of 1 was as potent as that of CAZ, and 1 had far better activity against /Mactamase-producing Gramnegative bacteria, E. coli, Klebsiella oxytoca, Morganella morganii and Enterobacter cloacae, compared to CAZ.Furthermore, the antibacterial spectrum of 1 covered anaerobic bacteria including Clostridium and Bacteroides as shown in Table 2 . The acute intravenous toxicity of 1 in mice was very low (LD50 > 5 g/kg), whereas the corresponding 1-carboxy-l-methylethoxyimino compounds 14 and 17 were more toxic (LD50<lg/kg).
It is noteworthy that the difference of one methyl group between the ($)-!-carboxyethoxyimino and 1-carboxy-l-methylethoxyimino substituents in this series influences both the activity and toxicity. Therapeutic Effect in Mice The subcutaneous administration of 1 exhibited marked therapeutic activity against systemic infections in mice, as shown in Table 3 . The therapeutic effect of 1 against all infections tested with E. coli, 
Penicillinase producer. b Cephalosporinase producer. K. pneumoniaeand P. aeruginosa was superior to that of CAZ.
Expe riment al
General Methods MP's were determined in capillaries and uncorrected. XHNMRspectra were recorded on a Jeol JNM-GX400(400 MHz) or on a Hitachi R-90 (90 MHz)spectrometer. IR spectra were taken on a Hitachi 260-10 spectrophotometer.
To a stirred solution of diphenylmethyl (S)-2-hydroxypropionate (10, 4.3 g) in DMF(25 ml) at -40°C was added sulfuryl chloride (1.62ml) dropwise. The solution was kept for 1 hour at room temperature. The reaction mixture was partitioned between EtOAc (40 ml) and ice-water (90 ml) containing NaHCO3 (8 g). The organic layer was separated and washed with NaCl-satd water (40mi x 2) and water (40ml). The separated organic layer was dried over MgSO4,filtered and concentrated to give crystalline 3 (3.6 g, Diphenylmethyl (5)-2-Chloropropionate (1 1) To a stirred solution of 10 (4.0 g), phenoxyacetic acid (2.49 g) and triphenylphosphine (4.9 g) in THF (100ml) at 0°C was added diethyl azodicarboxylate (3.45ml) in one portion. The solution was stirred at roomtemperature overnight and concentrated to give an oily residue. The residue was extracted with ether (100ml) and filtered. The extract was concentrated and the cone was purified by silica gel column chromatography (Wakogel C-100, Wako Pure Chem. Ind., 300g) with toluene as an eluent to give 12 as an oil (5.7g, 94%), [a]£5 +29.7°(c 5.0, CHC13). Compound 12 was dissolved in 50ml of MeOHand treated with 0.7 ml of 25% NH4OHat room temperature with stirring. After 1 hour, the reaction mixture was adjusted to pH 7.0 with 0.1 n HC1 and evaporated. The residue was partitioned between EtOAc (50 ml) and H2O (50ml). The organic layer was concentrated and the residue was purified by silica gel column chromatography with toluene -EtOAc (10 : 1) as an eluent to give diphenylmethyl (iQ-2-hydroxypropionate (2.7g, 73%), mp 80~82°C, [a]£5 +9.10°(c 5.0, CHC13). It was converted into ll by the method used for R isomer 3, in 80% yield, mp 56~59°C, [a]£5 -7.62°(c 5.0, CHC13).
Allyl 2-(2-Tritylaminothiazol-4-yl)-2-hydroxyiminoacetate (2) Ethyl 2-(2-tritylaminothiazol-4-yl)-2-hydroxyiminoacetate5) (3.0 g) was suspended in 36 ml of allyl alcohol and he.ated at 60°C with stirring. To the suspension was added 200 mg of sodium ethoxide dissolved in 1 ml of allyl alcohol. The mixture was sitrred at 60°C for 3 hours and then cooled to room temperature. After neutralization with 0.15 ml of 2n HC1, the mixture was concentrated and triturated with 10ml of isopropyl ether to give the crude powder (2.6 g), which was partitioned between 15ml of CHC13and 10ml of H2O. The organic layer was separated, dried over MgSO4and concentrated to 7ml. Addition of 10ml a solution of2 (3.1 g) in DMSO(16.5ml) was added 3 (2.0g) and K2CO3(powdered, 1.82g ) at room temperature with stirring. The mixture was stirred overnight and partitioned between EtOAc(60 ml) and ice-water (30 ml). The organic layer was separated and washed with NaCl-satd aq solution (30 ml) containing 0.13 ml of 2n HC1 (pH 7.0). The organic layer was separated, dried over MgSO4,filtered and concentrated to 6 ml. The cone containing 4 was dissolved in CH2C12(40 ml) and treated with triphenylphosphine (180 mg) and tetrakis(triphenylphosphine)palladium (34mg). To the stirred solution potassium 2-ethylhexanoate (1.26 g) in EtOAc (13 ml) was added under N2 atmosphere and stirred for 2 hours. After trituration with isopropyl ether (45 ml), the potassium salt (5a) was obtained by filtration. The potassium salt was partitioned between EtOAc (65ml) and ice-water (26ml) and adjusted to pH2.8 with 2n HC1 (3.4 ml). The organic layer was separated, dried over MgSO4and concentrated to give crystalline 5b (2. 1 3 g, (6, 1.32g, 3.6mmol) and 5b (2.4g, 3.6mmol) in CH2C12 (40ml) was added pyridine (1.45ml) at 0°C. The mixture was stirred for 1 hour to give a solution, cooled to -10°C and followed by addition ofphosphoryl chloride (0.35 ml, 3.96 mmol). After 1 hour, the mixture was concentrated, diluted with EtOAc (54ml) and washed with NaCl-satd water (30 ml). The organic layer was separated, dried over MgSO4and concentrated to give 7 as a foam (3.2g, 87%). The product was used without further purification for the next step. 
Compound 7 (3.70g, 3.6mmol) and l-ethylpyrid-4-thione (8, 0.5g, 4.07mmol) were dissolved in DMSO (ll ml) and stirred at room temperature for 1 hour. To the reaction mixture was added CHC13 (23 ml), EtOAc (10ml) and NaCl-satd water (20ml). The organic layer was separated, washed with H2O (10ml x 2), dried over MgSO4and concentrated to give 9 (3.6g, 85%). To a solution of9 in anisole (5ml) was added 88% formic acid (4ml) and coned HC1(2ml). The solution was stirred at room temperature for 4 hours, diluted with isopropyl alcohol (100ml) and adjusted to pH 3.5 with 25% NH4OHwith ice cooling. After stirring at room temperature overnight the resulting ppt was collected and dried to give 1 as a free amine (1.6g, 78% from 9). The free amine was dissolved in H2O (8ml) and followed by addition of coned HC1 (1.4ml, 6 equiv) at 5°C. The solution was diluted with acetone (15ml) and stirred overnight at 5°C to give the crystalline dihydrochloride of 1, which was washed with acetone (5 ml) and JAN. 1990 dried 
